Comparative Effectiveness for AI MedTech
Published on: 04/09/2024
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
Payer Coverage
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
What AI MedTech founders need to know about payer expectations and evidence standards.
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
“Clinical utility” is one of the most misunderstood payer terms. This article explains what U.S. payers expect and how to prepare.